Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of the combination of semaphorin-4D inhibitory molecules and VEGF inhibitory molecules to inhibit angiogenesis

Use of the combination of semaphorin-4D inhibitory molecules and VEGF inhibitory molecules to inhibit angiogenesis

US Patent 8790652 · Granted Jul 29, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CCR8 antibodies and uses thereof2025
Combination therapy with semaphorin-4D blockade (SEMA4D) and DC1 therapy2025
Use of semaphorin-4D antibodies in combination with an immune modulating therapy2024
Use of semaphorin-4D antibodies in combination with an immune modulating therapy2024
Anti-CD100 antibodies and methods for using the same2024
Human anti-semaphorin 4D antibody2024
Anti-CXCL13 antibodies and methods of using the same2024
Integral membrane protein display on poxvirus extracellular enveloped virions2024
Anti-CCR8 antibodies and uses thereof2024
Combination therapy with semaphorin-4D blockade (SEMA4D) and DC1 therapy2023
Use of semaphorin-4D binding molecules for the treatment of Rett syndrome2023
Treatment of cancer with a semaphorin-4D antibody in combination with an epigene2023